Skip to content

disease.nz

Your Daily Health News
Main navigation
Medical Editor October 10, 2020

Takeda strikes $1B biobucks deal with Arrowhead for genetic liver disease asset – FierceBiotech

Takeda strikes $1B biobucks deal with Arrowhead for genetic liver disease asset  FierceBiotech
Bookmark the permalink.

Recent Posts

  • Survey of kauri trees in Waitākere Ranges will reveal for the first time the prevalence of dieback disease – Newshub
  • Researchers pinpoint how Zika virus evades cell’s antiviral response
  • Scientists identify therapeutic target for Epstein-Barr virus
  • Respiratory viruses that hijack immune mechanisms may have Achilles’ heel
  • As nations decide to live with the virus, some disease experts warn of surrendering too soon – The Washington Post

Recent Comments

    |
    Footer navigation
    • Privacy Policy